Kura Oncology, Inc.
KURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $776 | $505 | $577 | $759 |
| - Cash | $95 | $82 | $51 | $224 |
| + Debt | $19 | $19 | $19 | $17 |
| Enterprise Value | $700 | $443 | $545 | $551 |
| Revenue | $21 | $15 | $14 | $54 |
| % Growth | 35.7% | 8.4% | -73.8% | – |
| Gross Profit | $18 | $15 | $14 | $54 |
| % Margin | 84.5% | 100% | 100% | 100% |
| EBITDA | -$74 | -$66 | -$65 | -$17 |
| % Margin | -356.4% | -428.5% | -458.6% | -30.8% |
| Net Income | -$74 | -$66 | -$57 | -$19 |
| % Margin | -357.2% | -432.5% | -407.1% | -35.7% |
| EPS Diluted | -0.85 | -0.75 | -0.66 | -0.22 |
| % Growth | -13.3% | -13.6% | -200% | – |
| Operating Cash Flow | -$81 | -$29 | -$72 | $269 |
| Capital Expenditures | -$3 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$83 | -$30 | -$72 | $269 |